IL-1β and TNF-α may alter stromal cells enhancing the expression of CCL2, CXCL8, and CCL5 by cancer-associated fibroblast and mesenchymal stem cells in the inflammatory tumor microenvironment of breast cancer [15]. This evidence concerns the gene CCL2 and neoplasm.